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Analysis of a 55 kDa Plasma Protein(s) from Biomphalaria glabrata Associated with
Resistance to the Human Blood Fluke Schistosoma mansoni (81 pages)
Director: Willard O. Granath, Jr. (juOJSr,
Plasma (cell-free hemolymph) factors are involved in resistance o f the snail,
Biomphalaria glabrata, to the human blood fluke. Schistosoma mansoni. A 55 kDa
polypeptide(s) in plasma from a schistosome-resistant strain o f B. glabrata (10-R2),
but not from schistosome-susceptible snails (M-line), was previously shown to bind to
larval S. mansoni. This thesis took 5 approaches to further characterize the 55 kDa
polypeptide(s) and other plasma factors from both resistant and susceptible strains of
B. glabrata. The 55 kDa polypeptide(s) from 13-16-Rl (resistant) B. glabrata was
found to bind to sporocysts when they were alive, but when the sporocysts were
chemically-fixed binding of the 55 kDa polypeptide diminished as much as the 210
kDa polypeptide increased. Excretory-secretory products produced by living
sporocysts probably cleaves the 55 kDa from the 210 kDa polypeptide. Antibodies
generated to the isolated 55 kDa polypeptide(s) from M-line (anti-M-55), 13-16-Rl
(anti-Rl-55) and 10-R2 (anti-R2-55) B. glabrata reacted with the majority o f B.
glabrata plasma proteins. Therefore, antibodies not specific for the 55 ld)a
polypeptide(s) were immunoprecipitated. The remaining (isolated) antibodies were
specific for certain 55 kDa polypeptide(s). Isolated anti-M-55 and anti-Rl-55
antibodies reacted stronger to the 55 kDa polypeptide(s) from schistosome-susceptible
(M-line) and schistosome-resistant (10-R2) plasma than from schistosome-resistant
(13-16-Rl) plasma. This suggests that the molecular structures serving as epitopes on
the 55 kDa polypeptides(s) are not the same structures which give this polypeptide(s)
from schistosome-resistant snails the ability to bind to sporocysts. These and other
data suggested that certain plasma proteins possess more than one cross-reactive
epitope and these cross-reactive epitopes are more prevalent on certain polypeptides.
An immunoprécipitation procedure to remove common antigens between schistosomesusceptible and resistant plasma indicated that anti-M precipitated a 41 kDa
polypeptide from M-line but not from 13-16-Rl or 10-R2 B. glabrata. Experiments
designed to determine the carbohydrate binding specificity o f B. glabrata plasma
proteins indicated that certain proteins were inhibited from binding to zymosan by
mannan but the sugar N-acetyl-neuraminic acid caused most B. glabrata plasma
components to bind to zymosan. Lastly, analysis of B. glabrata plasma by twodimensional electrophoresis indicated that three groups of proteins in the molecular
weight range of 55 kDa exist in M-line, 13-16-Rl and 10-R2 B. glabrata and all of
them are immunogenic. Results of this thesis indicates that B. glabrata plasma
proteins are similarly immunogenic, but differences in the antigenicity o f speciflc
polypeptides exist. These data will be useful in future experiments designed to reveal
the significance of the carbohydrate and antigenic nature of plasma polypeptides in
immunity of B. glabrata to schistosomes.
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Chapter 1
Introduction
Human schistosomiasis is a debilitating disease caused by any one of five
digenetic trematodes of the genus Schistosoma: S. mansoni^ S. haematobium^ S.
japonicum^ S, intercalatum and S, mekongi (Mahmound, 1992). The World Health
Organization estimates that presently at least 200 million people in the world are
infected with a schistosome species and approximately 200 thousand people die each
year from the disease schistosomiasis (Guyatt and Evans, 1992). S. mansoni, the
species examined in this thesis, is widespread in tropical and subtropical Africa, South
America and the Caribbean (Katz et aL, 1989; Mahmound, 1992).
The life cycle of S. mansoni is complex. In humans, each sexually mature S.
mansoni female worm produces approximately 300 fully embryonated (miracidiacontaining) eggs each day (Katz et aL, 1989). About 50% of the eggs do not exit the
host and are swept via the blood stream into the lungs, spleen or liver where the host
responds to soluble antigens secreted by the eggs (Katz et aL, 1989; Weinstock,
1992). The damaging inflammatory reaction surrounding the eggs trapped in the liver
causes hepatosplenomegaly and portal hypertension. These symptoms are responsible
for most of the pathology of this disease (Stadecker, 1992). The remaining 50% of
the eggs exit the body in feces by working their way, with the aid of histolytic
enzymes, through the submucosa and villous tissue (Rollinson and Southgate, 1987).
The damage caused by this type of exit results in abdominal pain and diarrhea
(Weinstock, 1992). Unfortunately, in developing countries poor sanitation permits the
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eggs to reach fresh water (Huang and Manderson, 1992). Once the eggs reach water,
changes in osmotic pressure cause them to hatch and the fully embryonated miracidia
seek out a snail intermediate host (Jourdane and Theron, 1987). When a suitable snail
of the genus Biomphalaria is located via chemotaxis the miracidium penetrates the
fleshy tissues and rapidly transforms into a germinal sac, termed a mother sporocyst
(Noble and Noble, 1982). The fate of the mother sporocyst is dependent upon its
genetic makeup and that of the snail (Richards and Merritt, 1972). Some genetically
predetermined outcomes for the parasite are: (1) hemocytes (phagocytes) of
schistosome-resistant snails recognize, encapsulate, and destroy the larvae; (2)
hemocytes from unsuitable snails do not encapsulate the larvae but the parasite does
not develop for physiological reasons; (3) the larvae is recognized and encapsulated by
hemocytes but the parasite can develop normally; (4) hemocytes do not destroy the
parasite and the miracidium develops normally (Bayne et aL, 1980b; Richards, 1975a,
b; Richards et aL, 1992). Several strains of Biomphalaria glabrata are available for
study including the 10-R2 and 13-16-Rl strains, that are capable of destroying larval
S. mansoni, and the M-line-strain which allows for normal parasite development
(Richards and Merritt, 1972). Once a miracidium has transformed into a mother
sporocyst in a susceptible snail (e.g. M-line) the germinal cells lining the inner wall
develop into daughter sporocysts which will be liberated when the sac ruptures. The
next stage of maturation occurs when the germ cells in the daughter sporocyst develop
into cercariae (Noble et aL, 1989). Each asexual division results in a large numerical
increase of larval parasites. For example, each miracidium can give rise to 4,000
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cercariae and up to 40,000 cercariae can develop in an individual snail before the
snail becomes overwhelmed with the infection and dies (Katz et aL , 1989). In water,
cercaria emerge from a snail with the aid of proteolytic enzymes. The cercariae seek
out a human, or other definitive host, penetrate a hair follicle and transform to the
schistosomule stage in the subcutaneous tissue. After approximately two days in a
humans subcutaneous tissue the schistosomule enters the blood stream and migrates to
the capillaries of the lung, the heart and then the liver parenchyma where it matures
into an adult worm. Once mature, the worms choose their mate for life and pair up
with a worm of the opposite sex (Katz, et aL, 1989). Once paired, 5. mansoni
worms move to their final destination, the inferior mesenteric veins surrounding the
large intestine where the female begins laying approximately 300 eggs each day.
The drugs hycanthone, oxamniquine and praziquantel are useful in treating
humans with schistosomiasis. Unfortunately, chemotherapy for control of morbidity
and mortality has several limitations: (1) strains of 5. mansoni that are resistant to
hycanthone and oxamniquine have recently been reported (Cioli et aL, 1993); (2)
drugs are not affordable for most infected people (Presscott, 1987); (3) the prohibitive
cost of the skilled manpower required to administer the drugs in endemic countries,
(Butterworth et aL, 1992); (4) the drug(s) must be administered repeatedly at regular
intervals, (Wilkins, 1989); and (5) other drug resistant strains may arise if mass
chemotherapy is used (Dias et aL, 1982).
Due to these problems additional control measures are often used in conjunction
with chemotherapy. Measures to reduce fecal contamination into water have been
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attempted (e.g. toilets, water pipe systems and health education). Also, applying
moUuscicides has had some limited success (Fenwick, 1987; Klumpp and Chu 1987).
A problem with these solutions are the high cost and the lack of stable governments
(Liese, 1986). Although vaccines may prove valuable in decreasing the prevalence of
infection, to date, no vaccine for use in humans exists. An approach that has not yet
been attempted is to breed a B. glabrata snail strain that is 1(X)% resistant to S,
mansoni and introduce large numbers into endemic areas (Hubendick, 1958; Jame et
aL, 1993; Woodruff, 1978). The snails would act both as a sink for freshly hatched
miracidia and, hopefully, out-compete susceptible snails. Focusing on preventing the
disease by decreasing the number of vectors could, at very least, decrease the number
of worms with which an individual becomes infected. This would be significant since
the pathogenicity of the disease is directly correlated with the number of worms a
person harbors (Arap et al,, 1976; Chen and Mott, 1988; Lehman et aL, 1976). An
understanding of the immune factors of snails that permit or prevent parasite
development will be valuable if snails are to be manipulated for resistance. It would
seem necessary to breed a 100% resistant snail strain since flooding an endemic area
with snails that are not totally resistance may be counter-productive and result in the
introduction of additional genes for susceptibility into the snail population (Richards
and Merritt, 1972). In addition, identifying immune factors in the invertebrate may
aid in the development of a vaccine for humans (e.g. Capron et aL, 1987, 1991,
1992), provide knowledge useful in the development of molluscacides, identify novel
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aspects of the vertebrate immune system, and provide a greater understanding of the
basic biology of host-parasite immunobiology.
In an effort to elucidate the mechanism(s) of resistance, experiments described in
this thesis were performed to identify factors that endow genetically-resistant strains
of B. glabrata (10-R2, 13-16-Rl) with the ability to recognize S. mansoni (NIH-SmPR-1) sporocysts. Such results were compared to S. wa/uo/K-susceptible B, glabrata
(M-line). This comparison contributes to the identification of factors involved in
susceptibility and resistance of these snail strains to the parasite.
1.1. Literature Review
There are three interacting components that determine the fate of a schistosome
within a snail: a) snail plasma (cell-free hemolymph) factors, b) snail hemocytes, and
c) the larval parasite. Outstanding features of these interactions are that: a)
unidentiAed plasma factors from resistant snails, in some unknown way, enable
hemocytes of schistosome-susceptible B. glabrata to recognize and become cytotoxic
to the parasite (Bayne et al. 1980a, b; Granath and Yoshino, 1984); b) hemocytes
that recognize the parasite as foreign, encapsulate and destroy it by unknown
mechanisms (Loker and Bayne, 1982; Loverde et al. 1984; van der Knaap and
Loker, 1990), and c) parasite excretory-secretory (ES) products interfere with the
normal immune activities of B. glabrata (Connors et al., 1991; Lodes and Yoshino,
1990). The following review focuses on how plasma, hemocytes and sporocysts
interact.
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Plasma from 5. /Tw/wo/w-resistant B. glabrata can activate hemocytes from
schistosome-susceptible snails to kill sporocysts in vitro (Bayne et al. , 1980b) and in
vivo (Granath and Yoshino, 1984). In addition to the fact that susceptible hemocytes
possess the machinery needed to be cytotoxic (e.g. enzymes/receptors), other
information about activation of hemocytes by resistant plasma has been revealed.
First, since schistosome-resistant hemocytes are cytotoxic to sporocysts in the
presence of schistosome-susceptible snail plasma (Bayne et a h , 1980b; Loker and
Bayne, 1982), an inhibitory plasma protein that interferes with either a sporocyst or
hemocyte receptor is not likely to be responsible for susceptibility of snails to the
parasite. Secondly, since schistosome-resistant snail plasma is not cytotoxic to S.
mansoni sporocysts in vitro (Bayne, 1980a; Fryer et al. , 1989) the plasma factor(s)
that was transferred by Granath and Yoshino (1984) is not an enzyme or other
cytotoxic substance that acts directly on the sporocyst. Thus, the transferred factor
must have either activated hemocytes or marked the sporocyst for attack (Bayne et al.
1985). In an effort to identify the unique plasma factor(s) conferring resistance,
Spray and Granath (1988) used sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) to look for differences in plasma between susceptible
and resistant snail strains. When the plasma was solubilized without the reducing
agent 2-mercaptoethanol the only differences observed were quantitative. The M-line
strain also appeared to have more total protein than the 10-R2 strain and this was
continued using a protein assay. When 2-mercaptoethanol was added to the
solubilization buffer a difference in protein migration patterns was observed in the 55-
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kDa range in the resistant 10-R2 strain. This indicated a unique disulAde linkage of
proteins in this molecular weight region in resistant snails. Loker and Hertel (1987)
reasoned that the unique plasma protein(s) might be identiûed if a snail was exposed
to the parasite before analyzing the plasma by SDS-PAGE. These researchers
exposed schistosome-susceptible and resistant-B. glabrata to the trematode
Echinostoma paraensei eight days before obtaining plasma. Upon performing SDSPAGE on the plasma from the infected snails the only differences found were
quantitative.
Since schistosome-resistant snail hemocytes were cytotoxic in the absence of
plasma (Bayne et at. , 1980a) a strategy was developed to identify unique proteins
synthesized by hemocytes (Yoshino and Lodes, 1988).

Many methionine-containing

hemocyte proteins that were synthesized in vitro in response to schistosome ES
products were identified. Lodes and Yoshino (1993) later showed that hemocytesecreted proteins of 19 and 46 kDa from both resistant and susceptible snails bound to
sporocysts in vitro but no significant difference in the binding capacity of these
proteins between resistant and susceptible snails was found.
Since hemocyte-secreted proteins bind to sporocysts it was suggested that
sporocyst binding proteins could be involved in the snails immunorecognition of the
parasite (Bayne and Yoshino, 1989). It was also suggested that resistant but not
susceptible snails possess a unique agglutinin (Boswell and Bayne, 1985). Therefore,
snail plasma was examined for proteins with the ability to bind to sporocysts. When
interpreting results of such studies it is necessary to realize that sporocysts live in a
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snails hemolymph and, since the parasite contains no digestive system, nutrients are
obtained by absorption of certain hemolymph components (Bayne et al. , 1985, 1986;
Meuleman, 1972). In one in vitro experiment, sporocysts acquired various
components on the tegument within 20 minutes of being placed in snail plasma.
Maximum acquisition of plasma components was obtained at 3 hr, and within 12 hr
most plasma components could not be detected using Western blot analysis and SDSPAGE (Bayne et at. , 1986). In the same experiment live sporocysts were shown to
acquire the same molecular weight polypeptides between schistosome-resistant and
susceptible B. glabrata plasma but in different quantities.

In other mollusks, various

types of hemagglutinins and opsonins have been reported (Anderson and Good, 1976;
Arimoto and Trip, 1977; Prowse and Tait, 1969; Renwrantz and Cheng, 1977;
Renwrantz et aZ., 1981). In B. glabrata, many hemagglutinins (components which
agglutinate red blood cells) and non-hemagglutinins were identified which bound to
miracidia, sporocysts and cercariae but none were unique to resistant snails (Couch et
aL, 1990; Stein and Basch, 1979).
Spray and Granath (1990) used radiolabeled plasma to identify a 55 kDa
polypeptide unique to schistosome-resistant B. glabrata (10-R2) that adhered to living
sporocysts in vitro. It was hypothesized that this protein either acted as an opsonin to
aid hemocytes in recognizing the parasite or it agglutinated the parasite. Fryer and
Bayne (1989) identified a protein in this molecular weight range from resistant (10R2, 13-16-Rl), but not from susceptible (M-line) snails, that acted as an opsonin.
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Support for agglutinins in hemocyte-sporocyst interactions comes from Loker et
aL (1984). These authors observed that glutaraldehyde-fixed sporocysts of S.
mansoni agglutinated in plasma from schistosome-resistant B. glabrata (10-R2 and 1316-Rl), but did not agglutinate in plasma from schistosome-susceptible B, glabrata
(M-line, MRLc, L-311). In contrast, in this same study living sporocysts agglutinated
in both schistosome-resistant and susceptible plasma. This finding lead Spray and
Granath (1990) to hypothesize that the unique schistosome-resistant sporocyst-binding
55 kDa polypeptide was the protein responsible for the agglutination of fixed
sporocysts. Bayne et al. (1986) suggested that acquisition of plasma by the sporocyst
modified its tegument. An actual change in the conformation of the plasma
component after binding to the parasite could be responsible for the agglutination.
Indeed, the 55 kDa protein with the unique disulBde linkage described earlier, could
undergo a conformational change when bound to sporocysts which causes sporocysts
to agglutinate.
It appears that the 55 kDa plasma polypeptide does not play a role in hemocyte
cytotoxicity to sporocysts since schistosome-resistant hemocytes have been shown to
be cytotoxic in the absence of plasma factors (Bayne et aL, 1980a). Also, the 55 kDa
polypeptide was not synthesized by hemocytes (Lodes and Yoshino, 1989; Lodes and
Yoshino, 1993) indicating that hemocytes, after encapsulating a sporocyst, do not
synthesize and secrete the 55 kDa protein to aid in cytotoxicity.
It may be that agglutination of sporocysts by snail plasma may be a preliminary
step for hemocytes to become cytotoxic to the sporocyst (Spray and Granath, 1990).
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Hemocytes from susceptible (M-line) B, glabrata were shown in vitro to be cytotoxic
to sporocysts when the sporocysts were pre-incubated in the lectin concanavalin A
(Con A) (Boswell and Bayne, 1985). However, when hemocytes were the component
pre-incubated in Con A no cytotoxicity occurred to the sporocysts (Boswell and
Bayne, 1985; Loker et at,, 1989; Yoshino, 1981). This indicated that the components
that activate hemocytes were found on the sporocyst surface and not on the hemocyte
surface. These results led Boswell and Bayne (1985) to propose that Con A was
acting as a bridging molecule between the hemocyte and sporocyst. Indeed, Yoshino
(1981) found Con A determinates on B. glabrata hemocytes that could link the cells
to sporocysts. However, no difference in the molecular composition of the Con A
determinates between resistant (10-R2) and susceptible (M-line) B. glabrata
hemocytes was found.
Much effort has been directed at elucidating the mechanism of sporocyst/Con A
activation with the most convincing evidence being presented by Loker et al, (1989).
These investigators found that Con A modified the sporocyst tegument to enhance
hemocyte adherence and cytotoxicity. Tegument modulation was proposed because
once Con A was on the sporocyst surface anti-Con A antibodies coated the lectin
without inhibiting hemocytes from becoming cytotoxic. This indicated that once the
lectin was on the surface of the sporocyst, lectin-hemocyte contact was not required
for cytotoxicity to occur. Therefore, the lectin was not serving as a link between the
sporocyst and hemocyte. Although Con A per se is not present in snail plasma,
lectin-Uke molecules with agglutinating properties were found in B. glabrata plasma
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(Boswell and Bayne, 1985). Thus it is possible that a plasma component in resistant
snails binds to the sporocyst surface to enable hemocytes to become cytotoxic.
To determine if a resistant plasma component first binds to a sporocyst to allow
cytotoxicity, sporocysts or susceptible hemocytes were incubated in resistant plasma
and then mixed together (Loker and Bayne, 1982). Also, sporocysts, resistant-plasma
and susceptible-hemocytes were mixed at the same time. Results of various
combinations revealed that susceptible hemocytes were able to inflict damage to
sporocysts only when sporocysts, plasma and hemocytes were mixed at the same
time. This finding did not support or refute the hypothesis. The resistant plasma
component was necessary for cytotoxicity, but it could not be shown to bind to the
sporocyst before activating hemocytes to become cytotoxic. This failure may be
because living sporocysts or hemocytes pre-incubated in the resistant plasma, process,
destroy, shed or internalize the plasma bound to it (Bayne et al. , 1985; Yoshino,
1981). It is evident that induced cytotoxicity is complex but it can be studied by
asking the following: (1) what is on the sporocyst surface that serves as a receptor for
plasma or hemocytes? and (2) how do opsonins aid in recognition of foreign surfaces
by hemocytes?
Lectins, substances that recognize specific carbohydrates, have given much
information about the chemical composition of possible receptors on the sporocyst
surface. A variety of lectins bound to S. mansoni and E. paraensei sporocysts in
vitro (Uchikawa and Loker, 1991; Yoshino et aL, 1977). Differences in lectins with
galactosyl determinants for in v/>ro-transformed mother and daughter sporocysts have
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been described (Zeick and Becker, 1990). It is possible that lectins play a role in
immuno recognition of B, glabrata since molluscan hemocytes were shown to have
lectin binding sites on their surface (Parrinello and Arizza, 1988; Renwrantz and
Cheng, 1977; Yoshino, 1983), anti-lectin antibodies bound to hemocytes of the snail
L. stagnalis (van der Knaap et a/., 1981), and a lectin was isolated from oyster
hemocyte membranes (Vaste et al. , 1982). It is not know whether these hemocyteassociated lectin receptors play a role in resistance to schistosomes. In fact, Yoshino
(1981) showed that determinates for Con A Arom both susceptible and resistant
hemocytes were of the same molecular composition.
The means by which hemocytes from the mussel Mytilus edulis recognize foreign
surfaces in vitro was examined by Renwrantz and Stahmer (1983). These
investigators showed that yeast pre-incubated in plasma was phagocytosed because of
two specific plasma lectins; thus these lectins functioned as opsonins. Also, the
addition of Ca^^ to hemocytes enhanced phagocytosis of saline-suspended yeast which
led these researchers to propose that a divalent cation-dependent molecule occurs on
the hemocyte surface which activated the cell. Further, the glycoprotein mucin
inhibited both the opsonization of yeast cells to the surface of hemocytes and the
agglutinating activity of the isolated lectins. This suggested that both the plasma
lectins and the molecule on the hemocyte surface had similar recognition sites. In
another study. Fryer and Bayne (1989) used an in vitro yeast phagocytosis assay to
examine the carbohydrate specificity of opsonins for hemocytes of B. glabrata. They
found that a cell-bound opsonin for the yeast was inhibited by laminarin, but a plasma
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opsonin was inhibited by mannan. This indicated that the cell-bound and plasma
opsonin recognized different carbohydrates.
The role of plasma agglutinins/lectins emerging thus far is: (1) agglutinins could
be opsonic and/or could clump sporocysts to aid in hemocyte recognition; (2) specific
exogenous lectins modulate the sporocyst surface to allow cytotoxicity; and (3)
opsonic plasma proteins increase phagocytosis of foreign material and these
components could either have the same or different carbohydrate recognition sites for
foreign particles.
As previously discussed, carbohydrate molecules are very important in
immunorecognition in schistosome-snail interactions. These carbohydrates could also
be responsible for the cross-reactivity between sporocysts and snail plasma (Dissous et
aLy 1986). This was based on a study where antibodies generated to deglycosylated
plasma did not cross-react with miracidia whereas antibodies to glycosylated plasma
did cross-react. In addition, a monoclonal antibody to a 90 kDa glycosylated
component did not recognize this component if it was deglycosylated nor any
miracidial antigens if they were deglycosylated. In contrast, when the glycoproteins
were not deglycosylated the antibody bound both the 90 kDa component and miracidia
antigens.
Additional studies on carbohydrate epitopes have shown that mouse monoclonal
antibodies, generated to in vitro transformed sporocysts, recognized only carbohydrate
epitopes on the sporocyst surface (Boswell et al. y 1987). Some of these
glycoconjugates on the surface of S. mansoni sporocysts were pronase-sensitive and
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others were pronase-resistant. This indicated that the glycoconjugates were bound to
different proteins. Also, endoglycosidase had no effect on the binding of lectins to
the surface of living in Wrm-transformed sporocysts of S. mansoni or E, paraensei
(Uchikawa and Loker, 1991) indicating that the sugar residues were not cleaved by
this enzyme. Since the parasite was alive this study, the metabolically active
tegument could have either destroyed the enzymes or produced more of the sugars
against which the enzymes were targeted.
Numerous receptors that are most likely carbohydrates are present on the
sporocyst surface (Bayne et aL, 1984). These investigators showed that equivocal
amounts of two anti-sporocyst antibodies (IgG), with some overlapping specificities
for the sporocyst tegument, differentially affected cytoadherence (CA) of hemocytes.
This finding indicated that sporocysts have numerous receptors on their surface
involved with CA. These results occurred with both fixed and living sporocysts
indicating that the IgG was not modulating the sporocyst surface to allow CA. Also,
the F(ab ’ ) 2 from these antibodies affected CA in the same manner as did the intact
IgG molecule showing that interference caused by the intact antibody was not due to
stearic hinderance.
Encapsulating a sporocyst probably is an important preliminary step for
cytoadherence. Although both resistant and susceptible B. glabrata hemocytes
encapsulated sporocysts in vitro (Bayne et aL, 1984), when hemocytes from
schistosome-resistant snails encapsulated sporocysts, portions of the tegument was
phagocytosed (Lie, 1982; Lie et aL, 1987; Loker and Bayne, 1982), cytotoxicity was
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observed, and the sporocyst was killed (Bayne et aL, 1980b; Lo Verde et aL, 1984).
Conversely, hemocytes from schistosome-susceptible M-line B. glabrata encapsulated
S, mansoni sporocysts without damaging the sporocyst (Bayne et aL, 1980b, 1984;
Loker et aL, 1989). This observation indicated that more than just encapsulation of
sporocysts was involved with parasite destruction.
How B. glabrata hemocytes kill a sporocyst is unknown, but many cytotoxic
enzymes have been associated with the process. For example, alkaline phosphatase,
aminopeptidases, lysozyme and acid phosphatase levels increase in snail hemolymph
in response to infection (Cheng, 1978; Cheng and Butler, 1979; Kassim and Richards,
1978). Acid phosphatase was also detected around degenerating encapsulated
sporocysts (Cheng and Garrabrant, 1977). Using three lysosomal markers, acid
phosphatase, peroxidase and non-specific esterase, Granath and Yoshino (1983) found
that hemocytes from resistant (10-R2) B, glabrata had a greater distribution and
abundance of these enzymes than hemocytes from susceptible (M-line) B. glabrata,
and each strain had discrete hemocyte subpopulations based on these markers. Bayne
et aL (1980b) suggested that hemocytes from resistant B. glabrata (10-R2, 13-16-Rl)
exist in a naturally higher state of cytotoxic activation than susceptible (M-line) B.
glabrata. Although the mechanism of cytotoxicity is unknown, it could be related to
the production of reactive forms of oxygen (e.g. 0%, H 2 O2 ) as was demonstrated in
vitro by several groups (Connors et aL, 1991; Dikkeboom et aL, 1988; Shozawa et
aL, 1989; van der Knaap and Loker, 1990).
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If snails produce toxic molecules then a sporocyst must prevent or inactivate
these molecules to survive. Indeed, in vitro and in vivo studies with hemocytes from
B. glabrata infected with E. paraensei showed that the hemocytes had a reduced
ability to encapsulate and destroy 5. mansoni larvae or foreign particles (Lie, 1982;
Lie et aL, 1987; Lie and Heyneman, 1977; Loker et aL, 1986; Noda and Loker,
1989). To determine if the interference was acting on plasma or hemocytes, Noda
and Loker (1989) assayed phagocytosis by B. glabrata hemocytes incubated in
homologous or heterologous plasma from uninfected and E. paraensei-mfecXsd snails.
Their results revealed that hemocytes from uninfected snails consistently had elevated
levels of phagocytosis compared to hemocytes from infected snails. These results
were interpreted to mean that the essential regulating factor in phagocytosis was the
speciAc source of hemocytes rather than the plasma.
Noda and Loker (1989) observed that ES products of E. paraensei excreted in
vivo had no inhibitory effect on phagocytosis by hemocytes in vitro. This was
revealed when plasma from M-line B, glabrata^ infected for eight days with E.
paraensei, was used to pretreat sheep red blood cells (sRBC) and no inhibition of
phagocytosis was observed. Although speciAc ES products had been shown to
speciAcally interfere with hemocyte motility (Lodes and Yoshino, 1990) it appeared
that they did not affect hemocyte phagocytosis of a foreign particle pre-incubated in
ES products excreted in vivo. Also, the lack of inhibition could be a result of the in
vitro phagocytosis assay of a biologically irrelevant particle (sRBC) that did not allow
ES products to perform their normal in vivo function, or the ES products had been
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destroyed by the immune system of the snail. Hemocytes from E. paraefisei-infecied
snails capable of phagocytosing sRBC corroborates Lie et aL (1981) who showed that
B. glabrata still retained the ability to phagocytose foreign particles when infected
with echinostomes. Lie et al. (1981) also showed that an echinostome infection
caused B. glabrata to lose the ability to encapsulate different species of digenean
larvae. This indicated that the interference of the infecting echinostome was specific.
A 108 kDa ES protein from S. mansoni that had specific interfering abilities was
isolated by Lodes and Yoshino (1990). These investigators showed, in vitro, that this
108 kDa ES protein significantly inhibited the random motility of M-line, but not 10R2, hemocytes. In addition, Connors and Yoshino (1990) showed that resistant 10-R2
hemocytes maintained a higher degree of phagocytosis and superoxide production than
did susceptible M-line hemocytes in response to sporocyst ES products. Also, ES
products were shown to inhibit hemocyte protein synthesis (Lodes et aL, 1991).
1.2. Overall Objectives
From the above, it is clear that plasma factors play a significant role in
sporocyst/hemocyte interactions. The research described in this thesis was based
largely on the studies of Spray and Granath (1990) who identified a 55 kDa plasma
protein from schistosome-resistant B. glabrata (10-R2) that bound to living
sporocysts. This thesis focused on the characterization of the sporocyst and zymosancarbohydrate binding abilities, and the antigenic properties of the 55 kDa plasma
protein(s) from B. glabrata. In addition, immunoprecipiation and two-dimensional
electrophoresis were techniques used to identify unique antigens in B. glabrata plasma
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since unidentified plasma components from S. mansoni resistant snails enabled S.
mansoni-susceptibic hemocytes to become cytotoxic to sporocysts in vivo (Granath and
Yoshino, 1984).
1.3. Specific Research Goals:
1. To determine which *“ l-labeled plasma proteins from B. glabrata (13-16-Rl) bind
to in vi/ro-transformed living and chemically-fixed sporocysts.
2. To characterize the 55 kDa protein(s) present in M-line, 13-16-Rl and 10-R2
strains of B. glabrata. The 55 kDa protein from each strain was used to generate
antibodies in rabbits. Each of the rabbit sera containing the anti-55 kDa antibody was
used in Western blots to probe plasma from M-line, 10-R2, and 13-16-Rl B. glabrata
to determine if the antibody was specific for the 55 kDa protein against which it was
generated, or if specific strain differences could be detected.
3. To examine the effect carbohydrates have on altering the ability of snail plasma
components to bind to zymosan, a particle routinely used to investigate phagocytosis
by invertebrate hemocytes.
4. To immunoprecipitate common plasma antigens between schistosome-susceptible
B, glabrata (M-line) and schistosome-resistant B. glabrata (13-16-Rl, 10-R2) by
using an antibody created against M-line plasma. Plasma antigens not removed by the
antibody should be unique to schistosome-resistant snails.
5. To determine if the 55 kDa polypeptide dissociated to smaller molecular weight
polypeptides by two-dimensional SDS-PAGE. This will show if the 55 kDa breaks
down to smaller molecular weight polypeptides.
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6. Two-dimensional electrophoretic separations of M-line, 13-16-Rl and 10-R2 B.
glabrata plasma were probed with antibodies to plasma from these 3 strains of snails
to determine whether the 55 kDa or any other polypeptide was unique to schistosomeresistant snails.

Chapter 2
Materials and Methods
2.1. Maintenance of B. glabrata and Plasma Preparation.
The M-line (schistosome-susceptible), and the 13-16-Rl and 10-R2 (schistosomeresistant) strains of B, glabrata used in this study were maintained in continuous
culture in 40 liter aquaria that received constant filtration and aeration. Snails were
fed leaf lettuce ad libitum and were maintained at 26^0 in the dark. Hemolymph was
collected by headfoot puncture (Sminia and Barendsen, 1980) and placed in a glass
depression slide in a humiditied chamber for 1 hr to allow hemocytes to adhere to the
glass. Plasma was placed in 1.5 ml microfuge tubes, centrifuged for 10 min at
1,000g to pellet any remaining hemocytes, transferred to a new tube, and centrifuged
at 10,000g for 10 min to remove remaining particles. The plasma was used
immediately or frozen at -20®C.
2.2. Maintenance and Collection of 5. mansonU
Miracidia of S- mansoni (NIH-Sm-PR-1 strain) were collected (Yoshino et aL,
1977) and transformed to sporocysts in vitro using RPMI tissue culture medium
(Samuelson et aL, 1984) devoid of fetal calf serum. Sporocysts were washed (5X) in
phosphate-buffered saline (sPBS) isotonic with B. glabrata (Yoshino, 1981). If
sporocysts were not used immediately they were fixed for 20 min in a 0.1 %
glutaraldehyde solution, washed (5X) with Chemins balanced salt solution (CBSS)
(Chemin, 1963), washed (5X) with sPBS and stored in a 0.02% sodium azide-sPBS
solution at 4®C.
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2.3. Radioiodination of Plasma.
Plasma was labeled by placing 200 «1 into an lodogen ( 1,3,4,6-tetrachloro3a,6a-diphenylglycouril)-coated 1.5 ml microfuge tube. lodogen tubes were prepared
by placing 20 «1 of a 1.0 mg/ml solution of lodogen in chloroform into microfuge
tubes and allowing them to air dry. Next, 4.0 wl of

(ICN Pharmaceuticals, Irvine,

CA) (25 wCi/wl, 100 uCi total) was added and incubated on ice for 1 hr (Judd, 1987).
The resulting radiolabeled plasma was used in experiments described below. Methods
described by Spray and Granath (1990) were used to determine which radiolabeled
plasma polypeptides from 13-16-Rl B. glabrata bound to fixed S, mansoni
sporocysts.
2.4. Isolation of the 55 kDa Polypeptide(s).
Plasma was separated using preparative SDS-PAGE using the Tris glycine
system of Laemmli (1970). To isolate the 55 kDa protein, 10% (acrylamide: N ’,N’methylene-bis-acrylamide ratio, 30:0.8) slab gels with a 2.5% acrylamide stacking gel
was used. The 55 kDa band was excised with a razor blade and further purified using
a 12.5% SDS-polyacrylamide gel. The gel was electroblotted onto a nitrocellulose or
a nylon membrane using a transblot chamber (20 mM phosphate buffer pH 0.4; 0.5 A
for 18 hrs at constant 15 V). Following Coomassie Brilliant Blue (CBB) staining of
the membrane the 55 kDa band was cut out and placed into a 1.5 ml microfuge tube.
The procedure of Judd (1988) was used to remove the protein from the membrane.
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2.5. Two-Dimensional SDS-PAGE.
The 55 kDa polypeptide from M-line, 13-16-Rl and 10-R2 was excised from a
SDS-polyacrylamide gel (10%), solubilized for 10 min and re-subjected to SDS-PAGE
(10%) as described by Judd (1988). When solubilized the second time a 1:1 ratio of
solubilization buffer to protein was used.
2.6. Generation of Antibodies.
Antibodies to the 55 kDa protein(s) from 10-R2 B. glabrata were made by
mixing the protein in mammalian PBS (mPBS) with Freund's incomplete adjuvant,
(1:1) and injecting 0.5 ml subcutaneously into the axilla and inguinal areas of rabbits
(total of 2.0 ml injected). At 1 week intervals 2.0 ml of the 55 kDa antigen in mPBS
was injected intravenously. Starting at one month after initial injection blood was
collected from the rabbits. The titer of antibodies made with Freund’s incomplete
adjuvant was less than 10 so a RIBI adjuvant (synthetic trehalose dicorynomycolate
(S-TDCM)) (RIBI immunochem, Hamilton, MT) was used and the recommended
protocols were followed. Using this protocol, antibodies were created to the 55 kDa
polypeptide from M-line (anti-M-55), 13-16-Rl (anti-Rl-55) and 10-R2 (anti-R2-55)
B. glabrata. Rabbit serum was collected and stored using standard procedures.
Antibodies were also generated to whole plasma from M-line (anti-M), 13-16-Rl
(anti-Rl) and 10-R2 (anti-R2) B. glabrata.
2.7. Immunoblotting.
Samples of plasma, plasma plus sporocysts or isolated 55 kDa protein were
separated by SDS-PAGE and electroblotted onto membranes. Membranes were
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blocked with PBS containing 0.5% Tween and 2% milk for 1 hr. Antibodies were
initially diluted in the blocking agent at a 1:100 dilution and incubated with a
membrane for 1 hr. The membrane was washed 4X for 1 hr to remove unbound
serum and then protein A-peroxidase was added (1:1000) in blocking agent to allow
binding to antigen-antibody complexes. These complexes were detected using a
developer (60 mg 4-chloro-1-naphthol, 20 ml methanol, 100 ml 20 mM Tris 500 mM
NaCl, pH 7.2, and 100 «1 H2 O2 ). One hundred microliters of India ink in 25 ml dH20
was used to stain the membrane to reveal molecular weight markers and confirm the
transfer of proteins.
2.8. Removal of Cross-Reactivity.
Preparative SDS-PAGE was used to separate 400 u\ of plasma, prestained
molecular weight markers were at each end of the gel. The gel was blotted onto a
nitrocellulose or nylon membrane and the membrane was blocked with 0.5% tween2 % milk for 1 hr. Strips were cut from the left and right edges of the membrane,
stained with Coomassie Brilliant Blue (CBB) and laid next to the main portion of the
membrane to locate the 55 kDa protein. Once located, the 55 kDa region was excised
from the main portion of the membrane. This membrane, containing all B. glabrata
plasma proteins except the 55 kDa protein, was incubated in anti-55 kDa antibodies to
remove all antibodies not specific for the 55 kDa protein. Homologous combinations
of preparative membrane and antibody were used; for example, if the membrane
contained M-line plasma it was incubated in a dilution of anti-55-M. A dilution of
the remaining antibodies were tested to determine if they reacted with B. glabrata
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proteins other than the 55 kDa polypeptide. If cross-reacting antibodies remained the
procedure was repeated.
2.9. Protein Determination.
A 60 second microwave bicinchoninic acid (BCA) assay was used to measure the
concentration of protein samples (Akins, 1992).
2.10. Immunoprécipitation.
Two-hundred microliters of '^I-labeled plasma was added to an equal protein
concentration of anti-M-line antibodies. The quantity of protein in each plasma
sample was based on values obtained by Spray and Granath (1988). The plasmaantibody mixture was incubated for 1 hr with agitation at room temp (25®C). The
appropriate quantity of protein A sepharose, as recommended by the manufacture,
was added and mixed for 1 hr on a rocker. The antibody/antigen complexes were
pelleted by centrifugation at 10,000g for 5 min. The supernatants should have
contained plasma antigens not removed by the protein A-antibody/antigen
precipitation. These supernatant samples were characterized by SDS-PAGE and silver
staining. Upon first analysis, most proteins were not removed by the antibody so the
same amount of antibody was added to the remaining unsolubilized supernatant and
the incubations and precipitations were repeated. On the second analysis 1.5 as much
of the M-line supernatant than the 13-16-Rl and 10-R2 samples were loaded onto a
gel to clearly illustrate the absence of the 41 kDa polypeptide.
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2.11.

Zymosan/Plasma Incubation Experiments.

After bleeding snails, 100 ul of plasma was incubated with 1 % w/v of a specific
sugar for 1 hr. Sugars tested included glucose, mannan, N-acetyl-neuraminic acid
and glucosamine. Next, a 100 wl suspension of zymosan (yeast cell wall) was added
to the plasma and incubated for 1 hr to allow plasma components to adhere followed
by washing (4X) in CBSS to remove unbound plasma. Washing consisted of adding
500 wl of CBSS, vortexing, and centrifuging at 2 ,OCX) rpm for 2 min to pellet the

zymosan. The supernatant was discarded and fresh CBSS added; washing steps were
repeated 4X. Solubilization buffer was added to the zymosan pellet and the plasma
components that had bound were detected by SDS-PAGE.
2.12. Two-Dimensional Electrophoresis.
This procedure was conducted using methods described by BioRad (Hercules,
CA) with the following modifîcations.

All reagents used were put through a 0.45 wl

filter. Acylamide was stored at 4®C in a dark bottle. CalBioChem protein grade
detergent was used without diluting 1:10. Plasma proteins were solubilized in lysis
buffer for a minimum of 2 hr at room temperature. Fifty wl of plasma [lOmg/ml] was
sufficiently solubilized in 125 wl freshly made lysis buffer. After solubilized, samples
were ultracentrifuged at 100,000g overnight (minimum 8 hr). Prefocusing of gels
was not conducted. Tube gels were equilibrated for 5 min in SDS sample buffer
prior to running the second dimension. Gels were silver stained as described by
Dubray and Bezard (1982).

Chapter 3
Results
3.1. Radioiodination/Incubation Experiments.
The results of incubating *^I-labeled plasma from 13-16-Rl B. glabrata with
living or fixed sporocysts showed that both groups of sporocysts bound plasma
polypeptides of 210, 66 and 55 kDa (Fig. 1). Although there were no qualitative
differences in polypeptide acquisition between living and fixed sporocysts quantitative
differences were found. A 210 kDa polypeptide bound in much greater quantities to
fixed compared to living sporocysts. Accompanying the 210 kDa polypeptides
increased binding to fixed sporocysts was a proportionate decrease in binding of a 55
kDa polypeptide.
3.2. Two-Dimensional SDS-PAGE.
When the 55 kDa polypeptide from M-line, 13-16-Rl and 10-R2 was excised
from a polyacrylamide gel, re-solubilized, and re-subjected to SDS-PAGE it
apparently disassociated into many smaller molecular weight polypeptides (Fig.2).
The majority of the 55 kDa polypeptide did remain at the same molecular weight. No
polypeptide disassociation products below the approximate molecular weight of 30
kDa were detected.
3.3. Immunoblotting.
Immunoblot analysis using anti-M-55 indicated that these antibodies cross-reacted
with most of the polypeptides from all B. glabrata strains (Fig. 3A). During the
process of removing cross-reactivity, certain polypeptides (e.g. 47 and 84 kDa
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regions) were recognized less or no longer reacted with the anti-M-55 antibodies (Fig.
3B). The 47 and 84 kDa regions also were the first regions not recognized by antiRl-55 and anti-R2-55 after removing cross-reactivity (Data not shown).
When cross-reactivity was removed from anti-Rl-55 (Fig. 4B) the antibodies
reacted much stronger to the 55 kDa polypeptide(s) Arom M-line and 10-R2 plasma
than the 55 kDa plasma polypeptide(s) from 13-16-Rl B. glabrata,
3.4 Immunoprécipitation.
Results of immunoprécipitation to remove common antigens between
schistosome-susceptible and resistant snails indicated that anti-M precipitated a 41 kDa
polypeptide from M-line plasma, but not from 13-16-Rl or 10-R2 B. glabrata plasma
(Fig. 5). The concentration of the 41 kDa protein normally present in M-line, 13-16Rl and 10-R2 B, glabrata plasma was shown in the control plasma lanes (Fig. 5).
Most proteins in B. glabrata plasma were not removed by anti-M (Fig. 5).
3.5 Zymosan/Plasma Incubation Experiments.
Certain sugars altered the binding of specific plasma components to zymosan
(Fig. 6). Alterations caused by a sugar was detected by comparing the polypeptide
profile when a sugar was present (GA, N, GL, M) to when the sugar was absent
(plasma + zymosan, (PZ)) (Fig. 6). N-acetyl-neuraminic acid increased the binding
of polypeptides in the range of 25 to 210 kDa. Also, N-acetyl-neuraminic acid
allowed components less than 55 kDa to bind to zymosan particles. When plasma
was preincubated with mannan before being added to zymosan, most plasma
polypeptides did not bind with the absence of hemoglobin being the most obvious.
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Figure 1. Autoradiogram of ‘^Habeled plasma from 13-16-Rl B, glabrata that
bound to living (L) and glutaraldehyde-fixed (F) S, mansoni sporocysts. Note band at
55 kDa that bound more intensely to living sporocysts and a band at 210 kDa that
bound more intensely to fixed sporocysts. Molecular weight markers are in
kilodaltons.
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Figure 2. The 55 kDa polypeptide(s) from 13-16-Rl, 10-R2 and M-line B. glabrata
plasma that was excised from a SDS-polyacrylamide gel (10%), solubilized for 10
min and re-subjected to SDS-PAGE (10%). Note the 55 kDa protein(s) disassociated
to smaller molecular weight polypeptides. Gel was stained with silver nitrate.
Molecular weight markers (MW) are in kilodaltons.
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Figure 3. Immunoblots of plasma from M-line (M), 10-R2, and 13-16-Rl (13-Rl) B,
glabrata probed with various antibodies. A. Blot was probed with antibodies to a 55
kDa plasma polypeptide(s) from M-line B. glabrata (anti-M-55).

Note that

antibodies to a purifred 55 kDa polypeptide(s) from M-line B. glabrata reacted with
the majority of B. glabrata plasma proteins. B. Blot was probed with anti-M-55
which had some cross-reactivity with other B. glabrata plasma proteins removed.
Cross-reactivity was attempted to be removed by incubating anti-M-55 with all M-line
B. glabrata plasma proteins except the 55 kDa polypeptide(s). Note that while
removing cross-reactivity, proteins in the 47 and 84 kDa regions from three strains of
B. glabrata plasma were not recognized by the remaining antibodies. Molecular
weight (MW) markers are in kilodaltons.
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Figure 4. Immunoblots of plasma from 13-16-Rl (13-Rl), 10-R2, and M-line (M) B.
glabrata probed with various antibodies. A. Blot was probed with anti-M-55 which
had most of its cross-reactivity with other B. glabrata plasma proteins removed.
Cross-reactivity was removed by incubating anti-M-55 with all M-line B. glabrata
plasma proteins except the 55 kDa polypeptide(s). After cross-reactivity was removed
from anti-M-55 the remaining antibodies reacted stronger to the 55 kDa protein(s)
from M-line and 10-R2 than from 13-16-Rl B. glabrata. B. Blot was probed with
antibodies raised to a 55 kDa plasma protein(s) from 13-16-Rl B. glabrata (anti-Rl55) which had most of its cross-reactivity removed. Cross-reactivity was removed by
incubating anti-Rl-55 with all 13-16-Rl B. glabrata plasma proteins except the 55
kDa polypeptide(s). After cross-reactivity with other B. glabrata proteins was
removed the anti-Rl-55 antibodies reacted stronger to the 55 kDa protein(s) from Mline and 10-R2 than from 13-16-Rl B. glabrata. Molecular weight (MW) markers
are in kilodaltons.
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Figure 5. Polypeptide profile of samples separated by SDS-PAGE (10%). Samples
included: supernatants (SUP) remaining after immunoprécipitation of plasma from B.
glabrata 13-16-Rl (13-Rl), 10-R2 and M-line (M) with antibody to M-line (anti-M);
B. glabrata plasma (PLA); anti-M antibodies (AB); protein A (PRA). Protein A was
used to pellet (AB)/plasma complexes. Note that a 41 kDa protein was removed from
the plasma of schistosome-susceptible snails (M-line) but was not removed from the
plasma of resistant snails. This unique plasma protein from 10-R2 and 13-16-Rl B.
glabrata is indicated with a star. The gel was stained with silver nitrate. Molecular
weight (MW) markers are in kilodaltons.
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Figure 6. SDS-PAGE (10%) profile of M-line B. glabrata plasma polypeptides that
bound to zymosan. Plasma was preincubated with galactose (GA), N-acetylneuraminic acid (N), glucose (GL), or mannan (M) for 1 hr prior to incubation with
zymosan. Controls included zymosan (Z) alone, plasma + zymosan (PZ), and
plasma diluted 1:10 in CBSS (P). Note that mannan inhibited most B. glabrata
plasma polypeptides and N-acetyl-neuraminic acid increased the binding of most B.
glabrata polypeptides to zymosan. The gel was stained with silver nitrate. Molecular
weight (MW) markers are in kilodaltons.
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Galactose or glucosamine had no effect on the binding capabilities of plasma to
zymosan.
3.6. Two-Dimensional Electrophoresis and Immunoblotting.
Two-dimensional electrophoresis revealed three groups of proteins in the
molecular weight range of 55 kDa exist in the plasma of M-line, 13-16-Rl and 10-R2
B, glabrata (Fig. 7A, 8A, 9A, respectively). Two polypeptides of approximately 55
kDa exist in the basic region of all plasma samples. A protein of 55 kDa in the
middle of the pi range and an acidic protein of approximately 55 kDa was also
present (Fig 7B, C, D; Fig 8A, B, C; Fig. 9A, B, C).
Antibodies to M-line, 10-R2 and 13-16-Rl plasma recognized the 55 kDa region
in all strains. Proteins of 55 kDa formed a string of polypeptides across twodimensional separated 13-16-Rl B. glabrata plasma probed with anti-R2 (Fig. 8D).
Polypeptides of 30 and 25 kDa from the acidic region, and polypeptides of
approximately 40 kDa, ranging from basic to acidic, often were not present and thus
could not react with the antibodies. Further repetitions of this experiment indicated
that these 25, 30, and 40 kDa polypeptides were often present in both silver stained
gels and immunoblots. When present on the immunoblots of M-line B. glabrata they
appeared similar to those polypeptides from 10-R2 and 13-16-Rl B. glabrata (data not
shown). Plasma polypeptides from 13-16-Rl B. glabrata also were occasionally
absent, i.e. polypeptides of approximately 40 kDa with a pi from basic to acidic (Fig.
8B, C). When the 40 kDa polypeptides appeared on the 13-16-Rl plasma
immunoblots, polypeptides from the basic end were missing.
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Figure 7. Two-dimensional electrophoresis of plasma from M-line B. glabrata. (A)
The isoelectric focused plasma was subjected to SDS-PAGE (12%) and stained with
silver nitrate. Note the three groups of polypeptides in the molecular weight range of
55 kDa indicated with stars and the polypeptides in the 32 kDa region indicated by an
arrow. Molecular weight (MW) markers are in kilodaltons. For B, C and D, M-line
isoelectric focused plasma was subjected to SDS-PAGE (12%), electroblotted to a
membrane, and probed with antibodies to 10-R2 B. glabrata plasma (anti-R2) (B),
antibodies to M-line plasma (anti-M) (C) and, antibodies to 13-16-Rl B. glabrata
plasma (anti-Rl) (D). Note the presence of the 55 kDa polypeptides and the absence
of the 32 kDa regions. Molecular weight (MW) markers in kilodaltons, for C and D,
are the same as depicted in B.
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Figure 8. Two-dimensional electrophoresis of plasma from 13-16-Rl B. glabrata.
(A) The isoelectric focused plasma was subjected to SDS-PAGE (12%) and stained
with silver nitrate. Note the polypeptides in the molecular weight range of 55 kDa
indicated with stars and the polypeptides in the 32 kDa range indicated with an arrow.
Molecular weight (MW) markers are in kilodaltons. For B, C and D 13-16-Rl
isoelectric focused plasma was subjected to SDS-PAGE (12%), electroblotted to a
membrane, and probed with antibodies to 10-R2 B, glabrata plasma (anti-R2) (B),
antibodies to M-line B. glabrata plasma (anti-M) (C) and, antibodies to 13-16-Rl
plasma (anti-Rl) (D). Note the three groups of 55 kDa proteins indicated with stars,
the 40 kDa proteins indicated with an arrowhead and the 32 kDa proteins indicated
with and arrow. Molecular weight (MW) markers in kilodaltons, for C and D, are
the same as depicted in B.
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Figure 9. Two-dimensional electrophoresis of plasma from 10-R2 B, glabrata. Note
the polypeptides in the molecular weight range of 55 kDa are indicated with stars and
the polypeptides in the 32 kDa region indicated with an arrow. (A) B, glabrata (10R2) plasma was isoelectric focused, subjected to SDS-PAGE (12%) and stained with
silver nitrate. Molecular weight (MW) markers are in kilodaltons. For B, C and D
10-R2 isoelectric focused plasma was subjected to SDS-PAGE (12%), electroblotted
to a membrane, and probed with antibodies to 10-R2 plasma (anti-R2) (B), antibodies
to M-line plasma (anti-M) (C) and, antibodies to 13-16-Rl B, glabrata (D).
Molecular weight (MW) markers in kilodaltons, for C and D, are the same as
depicted in B.
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Chapter 4
Discussion
A 55 kDa plasma polypeptide(s) from schistosome-resistant (10-R2) B. glabrata
has been shown to bind to living sporocysts (Spray and Granath, 1990). Based on
this observation, this thesis took five different approaches to characterize the 55 kDa
polypeptide(s) from schistosome-susceptible (M-line) and resistant (13-16-Rl, 10-R2)
strains of B. glabrata. The first was to determine whether the 55 kDa polypeptide(s)
from resistant B. glabrata bound to chemically-fixed sporocysts. Second, the
antigenic characteristics of the 55 kDa plasma polypeptide(s) from M-line, 13-16-Rl
and 10-R2 B, glabrata was examined by generating antibodies to this isolated
polypeptide(s) and using these reagents for immunoblot analyses. Third, the effect
carbohydrates have on the ability of the 55 kDa and other plasma polypeptides to bind
to zymosan was examined. Fourth, antibodies to M-line plasma were used to
immunoprecipitate M-line, 13-16-Rl and 10-R2 plasma to determine whether the 55
kDa or other plasma polypeptides were unique to 13-16-Rl and 10-R2 snails. Fifth,
plasma was subjected to two-dimensional electrophoresis, electroblotted to a
membrane, and probed with antibodies to determine whether there was more than one
antigenic subunit of the 55 kDa polypeptide.
The goal of the first set of experiments was to determine which radiolabeled
polypeptides of 13-16-Rl B, glabrata plasma bound to chemically-fixed 5. mansoni
sporocysts. This experiment was based partly on the results of Loker et al. (1984)
who found that schistosome-resistant (13-16-Rl, 10-R2) B. glabrata plasma
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agglutinated both tixed and living S, mansoni sporocysts whereas schistosomesusceptible (M-line) B. glabrata plasma only agglutinated live sporocysts. These
experiments indicated that schistosome-resistant plasma possessed polypeptides with
sporocyst binding specificity which caused the agglutination of tixed sporocysts.
Subsequent studies using ’^I-labeled B. glabrata plasma identified a 55 kDa
polypeptide unique to schistosome-resistant (10-R2) B. glabrata that bound to living
sporocysts (Spray and Granath, 1990). This finding led Spray and Granath (1990) to
hypothesize that the unique 55 kDa polypeptide from 10-R2 plasma may agglutinate
fixed sporocysts. It was also hypothesized that when the 55 kDa polypeptide was
bound to sporocysts it may act as a receptor or as an opsonin for hemocytes. Fryer
and Bayne (1989) showed that a protein of a similar molecular weight (57 kDa) was
an opsonin, in vitro, for yeast. Subsequent studies have shown, in vitro, that other B.
glabrata plasma components were opsonins for latex beads (Uchikawa and Loker,
1992), and when calcium ions were absent B. glabrata plasma lectins were required
for in vitro phagocytosis of sheep red blood cells (Zelck and Becker, 1992). To be an
opsonin for fixed sporocysts a polypeptide must be able to bind to the parasite, such
as the lectins that have been identified which bind to sporocysts (Zelck and Becker,
1990). These lectins do not exist in B. glabrata plasma and to date the only B.
glabrata polypeptide with sporocyst specificity is the 55 kDa polypeptide from 10-R2
snails. Therefore, before it can be determined if the 55 kDa from schistosomeresistant 13-16-Rl B. glabrata agglutinates, opsonizes or acts as a receptor on fixed
sporocysts it was determined whether this polypeptide bound to fixed sporocysts.
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Several difficulties exist in comparing the data in Fig. 1 to those from the study
conducted by Spray and Granath (1990). In the present study, data for polypeptides
from 13-16-Rl was obtained whereas Spray and Granath (1990) provided information
for M-line and 10-R2 B, glabrata. It is also possible that M-line plasma possesses
polypeptides in the 55 kDa region that would have adhered to fixed sporocysts in this
assay. However, Spray and Granath (1990) showed that M-line plasma did not
possess a 55 kDa polypeptide with the ability to bind to living sporocyst. A second
difficultly is that Spray and Granath (1990) found living S. mansoni sporocysts to
acquire 10-R2 B. glabrata plasma polypeptides of 210, 180, 116 and 55 kDa whereas
in this study, living sporocysts acquired 13-16-Rl B. glabrata plasma polypeptides of
210, 66 and 55 kDa. Further, 13-16-Rl and 10-R2 B. glabrata are different snail
strains which may complicate generalizations about properties of resistant B. glabrata.
In spite of these difficulties both 13-16-Rl and 10-R2 are schistosome-resistant,
plasma of both agglutinate S. mansoni sporocysts and both have the unique 55 kDa
polypeptide that adhere to living sporocysts. Thus, results presented in this first
series of experiments of the thesis were evaluated using the hypothesis of Spray and
Granath (1990).
The results of incubating glutaraldehyde-fixed and living parasites with equal
counts per min of a *^I-labeled plasma sample from 13-16-Rl B. glabrata showed
that three polypeptides (210, 66, 55 kDa) bound to both fixed and living parasites
(Fig. 1). When the parasites were fixed, however, more of the 210 and less of the 55
kDa polypeptide bound. This decrease in binding of the 55 kDa polypeptide appeared

50
equivalent to the increased amount of 210 kDa polypeptide that bound. An
explanation for this result is that living sporocysts excrete proteinase(s) which cleaved
the 55 kDa polypeptide(s) from the 210 kDa polypeptide. However, when plasma
was incubated with fixed sporocysts no proteinase(s) would be present to cleave the
55 kDa polypeptide from the 210 kDa polypeptide.
Support for live parasites possessing such proteinases comes from the finding
that miracidia, the stage of the parasite that transforms to sporocysts, were shown to
contain neutral exopeptidase and leucine aminopeptidase (Bogitsh, 1983: Xu and
Dresden, 1986). More significantly, cysteine proteinase(s) active on high molecular
weight snail plasma proteins were detected in the culture medium when miracidia
transformed to sporocysts (Lodes and Yoshino, 1993). These proteinase(s)
recognized substrates containing arginine in the PI position and the hydrophobic
amino acids (leu, phe) at P2. If such a proteinase(s) was responsible for the results in
this thesis it would be expected that the proteinase(s) secreted from live sporocysts
would cleave the 55 kDa from the 210 kDa polypeptide. For fixed sporocysts it
would be expected that such a proteinase(s) would not be secreted and, therefore, less
of the 55 kDa polypeptide would be produced to bind to sporocysts. This expectation
offers an explanation for the results which showed that less of the 55 kDa was bound
to Axed sporocysts (Fig. 1). Hence, it seems likely that the quantity of the 55 kDa
polypeptide that bound to living or Axed S. mansoni sporocysts was dependent upon
the enzymatic action of the proteinase(s) identified by Lodes and Yoshino (1993).
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The presence or absence of certain parasitic enzymes could also have affected the
results of an experiment performed by Loker et al. (1989). They found that when E.
paraensei redia and sporocysts were fixed, hemocyte adherence was significantly
increased as compared to when the parasite was alive. When using Axed parasites the
proteinase(s) and other components which may aid in degrading hemocyte membrane
proteins would be absent. This absence may have allowed hemocyte adherence to
increase.
Other enzymes exist which may influence the results of experiments comparing
fixed and living parasites. For example, cercariae have recently been shown to
possess a phospholipase specific for glycosylphosphatidylinositol (Hawn and Strand,
1993). Living sporocysts may also possess phospholipase and this enzyme may allow
the sporocyst to alter specific regions of its tegument.

The absence of such

phospholipases from fixed sporocysts may have affected the outcome of experiments
performed in this thesis and by those conducted by Loker et al. (1989).
Outside of enzymatic cleavage, there are three alternative explanations for why
fixed and living sporocysts obtained different quantities of the 210 and 55 kDa
polypeptides. One explanation is that the 210 kDa polypeptide that bound to fixed
sporocysts may not have been completely solubilized. Thus, an analysis of this
sample by SDS-PAGE would show more of this polypeptide to be present.
Incomplete solubilization has previously been demonstrated with B. glabrata plasma
(Fig. 2; Spray, 1989). The 55 kDa polypeptide(s) from three strains of B. glabrata
was excised from a polyacrylamide gel, re-solubilized, and re-subjected to SDS-
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PAGE (Fig. 2). This gel indicated that the 55 kDa polypeptide disassociated to many
smaller molecular weight proteins but it did not re-aggregate to form higher molecular
weight proteins. Spray (1989) also showed that when plasma from M-line B.
glabrata was separated by SDS-PAGE, cut out of the gel and re-subjected to SDSPAGE, many of the proteins disassociated to lower molecular weight polypeptides of
which the 55 kDa polypeptide was often the only disassociation product. Apparently,
complete solubilization was not achieved in the two former experiments. In the
present study, it is possible that incomplete solubilization of the 210 and 55 kDa
polypeptides was responsible for the quantitative differences in polypeptide adherence
to fixed and living parasites (Fig. 1). However, this seems unlikely because
polypeptides that bound to sporocysts were solubilized in a higher ratio of
solubilization buffer to protein than in the previously discussed studies. In addition,
both samples of polypeptides that bound to fixed and living sporocysts were treated
with the same solubilization buffer and boiled for the same amount of time. As the
solubilization buffer used was denaturing and reducing the 55 kDa subunit would have
to be associated with the 210 kDa molecule by forces other than hydrogen-bonds and
disulfide linkages.
A second explanation for the observed quantitative differences in polypeptide
acquisition between living and fixed sporocysts is that the 210 and 55 kDa
polypeptides had different affinities for fixed sporocysts. Glutaraldehyde-fixation,
which cross-links proteins, may have altered the surface structure of the sporocysts
tegument. These alterations may have caused the 55 kDa polypeptide to have a lower
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affinity for the sporocysts and the 210 kDa polypeptide to have a higher affinity.
Support for certain polypeptides having different afGnities for the surface of fixed
sporocyst comes from Lodes and Yoshino (1993). They found that M-line and 10-R2
B, glabrata hemocytes synthesized two polypeptides (19 and 46 kDa) that adhered to
living sporocysts. However, when sporocysts were fixed, less of the 19 kDa
polypeptide and none of the 46 kDa polypeptide adhered. The reasons for these
quantitative and qualitative differences between living and fixed parasites is unknown.
Since Lodes and Yoshino (1993) only washed their sporocyst polypeptide samples two
times, a decrease in affinity of the 19 and 46 kDa polypeptides for the fixed
sporocysts could account for their results. In the current study, sporocyst-'^I-plasma
mixtures were washed with sPBS until the radioactive counts stabilized (usually more
than ten times). After extensive washing the polypeptides that remained bound to
sporocysts had a high affinity. Possibly, the 210 kDa polypeptide had a higher
affinity for the tegument of fixed sporocysts while the 55 kDa polypeptide had a
decreased affinity. This possibility is not favored since both fixed and living parasitepolypeptide samples were washed an equal number of times.
A third explanation for the observed quantitative differences in polypeptide
acquisition to fixed sporocysts (Fig. 1) is that when fixed, parasites may no longer be
able to interfere with the attachment, shedding, or modulation of the 210 kDa
polypeptide. Support for living sporocysts interfering with the immune components
of snails was presented by Fryer and Bayne (1990). They found that once 5. mansoni
had infected M-line B, glabrata, a reduction in hemocyte phagocytosis occurred in the
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presence of plasma, but not in its absence. The interference was found to be directed
at hemocytes. Although not noted by Fryer and Bayne (1990) it is apparent that this
interference must have been mediated through components in snail plasma. When
Lodes and Yoshino (1993) incubated fixed sporocysts with hemocyte secreted
polypeptides the binding of a 19 kDa polypeptide was decreased and a 46 kDa
polypeptide did not bind. These investigators took the proper precautions of
incubating the sporocysts and plasma at 4®C in the presence of sodium azide (Dunn
and Yoshino, 1991) to prevent fixed sporocysts from shedding or altering acquired
polypeptides. Nevertheless, the authors speculated that fixed sporocysts could have
shed or modulated acquired polypeptides. The main problem with this speculation is
that fixed sporocysts have no metabolic capacity to shed or modulate bound plasma
components. An additional problem with this speculation is that for a control,
sporocyst ES products were pre-incubated with the hemocyte-secreted polypeptides for
24 hr before the addition to sporocysts but no effect on polypeptide binding was
observed. It appears that if ES products affect polypeptide acquisition to sporocysts
the living sporocysts must be present to provide unknown factors that facilitate the
action of the ES products.
Additional studies on sporocyst-polypeptide interactions showed that living
sporocysts acquired B. glabrata polypeptides from both schistosome-resistant and
susceptible B. glabrata (Bayne et aL, 1986; Spray and Granath, 1990; Lodes and
Yoshino 1993). Bayne et al. (1986) used polyclonal antibodies generated to
hemoglobin-depleted plasma of schistosome-susceptible (M-line) and resistant (10-R2)
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B, glabrata to determine, in vitro^ if M-line and/or 10-R2 B, glabrata plasma proteins
would bind to sporocysts. Unique polypeptides were not detected, but different
quantities of polypeptides from both snail strains bound to the living sporocysts.
Since Spray and Granath (1989) showed that M-line and 10-R2 B. glabrata plasma
only had subtle differences in polypeptide profiles, these authors indicated that the
method used by Bayne et aL (1986) actually detected the commonality between M-line
and 10-R2 B. glabrata.
In contrast to Bayne et al. (1986), experiments in this thesis have identiAed
speciAc polypeptides from schistosome-resistant B. glabrata that adhered to
sporocysts, with quantities differing between Axed and living parasites. The drastic
decrease in the amount of the 55 kDa polypeptide that bound Axed sporocysts (Fig. 1)
makes it unlikely that, as an isolated protein, this polypeptide would be responsible
for the agglutination of Axed sporocysts as hypothesized by Spray and Granath
(1990). It is possible that the 55 kDa polypeptide(s) remains associated with the 210
kDa polypeptide in the absence of living sporocyst proteinase(s). When the 210 kDa
polypeptide is associated, the 55 kDa subunit may mediate agglutination of Axed
sporocysts. Further study is warranted since the 55 kDa polypeptide was present on
the sporocyst tegument only after exposure to ES products. During penetration by a
miracidium, a schistosome-resistant snail may respond to a parasite proteinase(s) by
allowing cleavage of the 55 kDa polypeptide from the 210 kDa polypeptide.
Schistosome-susceptible snails may not possess the 55 kDa polypeptide with sporocyst
binding capabilities. To determine whether a biologically active 55 kDa is produced
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by the proteinase(s), parasite proteinase(s) could be isolated as described by Lodes
and Yoshino (1993), incubated with the isolated B. glabrata 210 kDa polypeptide and
then, by SDS-PAGE analysis, determine whether the 55 kDa is an end product.
When bound to the sporocyst it could be determined whether these 210 and 55 kDa
polypeptides act as receptors or as opsonins for hemocytes. A sporocyst opsonin or
recognition factor would be significant since molluscs have been shown to posses
plasma recognition factors (Anderson and Good, 1976; Dikkeboom et aL, 1985;
Fryer et aL, 1989), but none of these factors have been shown to bind to sporocysts.
The factor(s) determining if a protein binds to sporocyst may be dependent upon the
antigenic characteristic of the polypeptide.
A second series of experiments in this thesis studied the antigenic characteristics
of the 55 kDa polypeptide(s) from M-line, 13-16-Rl and 10-R2 B. glabrata by raising
antibodies to these polypeptides. Results indicated that antibodies to the 55 kDa
plasma protein from M-line snails recognized at least one common epitope in the
majority of the plasma proteins from M-line, 10-R2 and 13-16-Rl B. glabrata.

The

most obvious explanation for the cross-reactivity was that the antigen injected into the
rabbits included traces of other proteins. This explanation is not favored since the 55
kDa range was purified twice at two different percentages of acrylamide. It is
possible that traces of polypeptides in the 55 kDa range were present in the antigen
injected into the rabbits, but certainly not all of the polypeptides in B. glabratas
plasma were present in the antigen. The anti-55 kDa antibodies reacted with proteins
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greater than 200 kDa and it is highly unlikely that proteins of this size would
deviously migrate to 55 kDa at two different acrylamide percentages.
An explanation for why antibodies generated to a single B, glabrata plasma
polypeptide reacted with the majority of plasma polypeptides is that most of the
plasma components of B. glabrata are hemoglobin subunits or breakdown products
(Granath et aL, 1987). Confirmation of B. glabrata plasma proteins consisting
mainly of hemoglobin was obtained by Granath (1988). Using a heme-stain, the
majority of polypeptides in B. glabrata were shown to be hemoglobin or hemoglobin
subunits. It is interesting that polypeptides of approximately 50 kDa in hemoglobindepleted samples of plasma did not react with the heme stain. Using peptide
mapping. Spray and Granath (1989) also showed that five isolated polypeptides from
plasma of schistosome-resistant and susceptible strains of B, glabrata were
structurally homologous to the hemoglobin molecule. In fact, antibodies to isolated
hemoglobin reacted with the majority of B. glabrata plasma polypeptides separated by
HPLC (Granath et aL, 1987). These results confirm the hypothesis of Yoshino
(1983) that anti-jB. glabrata plasma antibodies react with hemoglobin-like determinates
on the membrane of B, glabrata hemocytes.
Other investigators have reported that antibodies to B, glabrata plasma crossreact with sporocysts, B. glabrata hemocytes, and B. glabrata plasma components
(Bayne et aL, 1987; Boswell et aL, 1987; Granath et aL, 1987; Granath and Aspevig
1993; Yoshino, 1983). Antibodies generated to the parasite cross-reacted with both
B. glabrata hemocytes (Abdul-Salam and Michelson, 1983) and plasma from patently
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infected B. glabrata (Loker et al. y 1986). It is apparent that epitopes common to
many components in this host/parasite system exist. The molecular nature of these
cross-reactive epitopes between B. glabrata and S. mansoni were shown to be
carbohydrate associated molecules (Dissous et al., 1986).
Bayne et al. (1987) also found antibodies to a purified B. glabrata plasma
component to cross-react with the majority of B. glabrata plasma components. These
authors were unable to achieve isolation of specific antibodies from polyvalent anti
sera. Therefore, a different method, which used B. glabrata plasma proteins to
remove the cross-reactive antibodies, was performed in this thesis to remove the
cross-reactivity from anti-55 kDa sera. While removing the cross-reactivity plasma
polypeptides in the 47 and 84 kDa regions from M-line, 13-16-Rl and 10-R2 B.
glabrata did not react with anti-M-55 (Fig. 3B), hence these polypeptides probably
possessed either fewer of the common epitopes or different epitopes for which the
antibodies had idiotypes. Cross-reactive antibodies to the 55 kDa polypeptide(s)
probably recognized carbohydrate epitopes since Dissous et al. (1986) showed that
antibodies made to components in this host-parasite system were specific to
carbohydrates. Because of this, cross-reactivity removed from anti-sera to the 55 kDa
polypeptide(s) probably removed antibodies specific for the dominant carbohydrates.
Possessing less of a common carbohydrate is a more likely explanation because when
immunoblots were counterstained to confirm protein transfer, the 47 and 84 kDa
polypeptides appeared equal in quantity to polypeptides that were recognized by the
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antibodies. Also, SDS-PAGE analysis of B. glabrata plasma showed that these 47
and 84 kDa polypeptide regions appeared equal in quantities between snail strains.
It is apparent that anti-M-55 was specific for the 55 kDa polypeptide(s) from Mline and 10-R2 B. glabrata plasma, but not for the 55 kDa polypeptide(s) from 13-16Rl B, glabrata (Fig. 4A). It is unlikely that the failure of anti-M-55 to recognize the
55 kDa polypeptide(s) from 13-16-Rl B. glabrata was due to a large number of
unique amino acid sequences for the following reasons: 1) antibodies generated to the
55 kDa polypeptide(s) from 13-16-Rl (anti-Rl-55) recognized the 55 kDa
polypeptide(s) from the other two B. glabrata strains (Fig. 4B); 2) these three B.
glabrata strains are closely related (Richards, 1975a, b); 3) the 55 kDa
polypeptide(s) from schistosome-susceptible M-line and schistosome-resistant 10-R2
B. glabrata were found to share structural homology when analyzed by twodimensional peptide mapping (Spray and Granath, 1989). A more likely possibility
for this lack of recognition (Fig. 4A) is that the 55 kDa polypeptide(s) from 13-16-Rl
snails has fewer or altogether different cross-reactive carbohydrate molecules to which
anti-M-55 could bind. Support for the 55 kDa polypeptide(s) from 13-16-Rl B,
glabrata having fewer carbohydrate molecules is that anti-Rl-55 reacted stronger to
the 55 kDa polypeptide(s) from M-line and 10-R2 B. glabrata than to the 55 kDa
polypeptide(s) from 13-16-Rl (Fig. 4B). Support for different carbohydrates
molecules comes from the finding that a B. glabrata plasma polypeptide was shown to
be recognized by two separate lectins with different carbohydrate specificities (Vietri
and Granath, 1992). Thus if a protein was no longer recognized by the remaining
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antibodies, the protein either had fewer or less of the common carbohydrate for which
these antibodies were specific.
The 55 kDa polypeptide(s) from both schistosome-resistant (10-R2) and
schistosome-susceptible (M-line) snails was recognized by anti-M-55 and anti-Rl-55.
Therefore, the common carbohydrate molecules that may have served as epitopes
probably are not involved with the sporocyst binding capabilities of the 55 kDa
polypeptide(s) from 10-R2 plasma. This conclusion would be specific for the
particular carbohydrate molecule(s) associated with the 55 kDa polypeptide since
carbohydrate molecules are complex and appear to be important in the parasitehemocyte interactions. In fact, anti-sporocyst antibodies interfered with hemocyte
adherence (Bayne et al. , 1984) and these antibodies probably were binding to
carbohydrates.
Due to the finding that antibodies raised to either schistosome larvae or B.
glabrata plasma were cross-reactive with B. glabrata plasma, an attempt was made to
isolate specific antibodies from polyclonal anti-sera (Bayne et aL, 1987). A specific
antibody would be indicative of more than one type of antigenic region serving as an
epitope for the antibodies. As previously mentioned, Bayne et al. (1987) attempted to
isolate specific antibodies from antisera generated to B. glabrata plasma proteins
using several methods, but these were very different from the technique used in this
study. Initially, their experiments utilized anti-sera raised to a B. glabrata
hemagglutinin (anti-HA). Anti-HA was incubated with plasma from B. glabrata
lacking the hemagglutinin but all of the antibodies were precipitated. Next, rabbit red
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blood cells were used to remove all of the hemagglutinin activity from M-line plasma
and then this plasma was used to immunoprecipitate anti-HA. Once again, all
antibodies were depleted from anti-HA. Next, antibody to 10-R2 B, glabrata plasma
was incubated with M-line plasma that was bound to a solid phase (CNBr-sepharose)
matrix to try and isolate a strain-specific antibody. Once again all antibodies were
depleted. In their last effort the plasma hemagglutinin was separated by SDS-PAGE,
blotted and incubated in anti-HA. The antibodies that had bound to the HA were
removed, isolated and tested for specificity to the hemagglutinin in 10-R2 and M-line
plasma. Antibody specificity was not achieved; cross-reactivity still existed. These
investigators thus concluded that a single polypeptide carried epitopes shared by the
majority of plasma proteins. In addition to the above, the data from experiments in
this thesis indicate, for the first time, that an antibody speciûc to a B. glabrata
plasma component can be isolated from a polyclonal mixture and that some plasma
components have multiple sites that serve as common epitopes.
In a third series of experiments a method was developed to assess the effect B.
glabrata carbohydrate binding polypeptides on phagocytosis by snail hemocytes.
Carbohydrate binding polypeptides (agglutinins/lectins) have been implicated as
factors influencing phagocytosis by B. glabrata hemocytes (Loker et al. , 1989).
Zymosan is a particle commonly used to monitor phagocytosis by snail hemocytes.
B. glabrata plasma was found to adhere to zymosan so it was determined if these
plasma components could be inhibited to binding to zymosan by preincubating with a
sugar (Fig. 6). When preincubated, the sugar should saturate carbohydrate binding
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receptors and inhibit the polypeptides from binding to zymosan (Fig. 6). When
plasma was incubated with mananan 180, 116, and 55 kDa polypeptides no longer
bound to zymosan. Galactose and glucosamine had no affect on polypeptide binding.
Interestingly, when N-acetyl-neuraminic acid was present more plasma components
bound to zymosan than when particles were not preincubated with a sugar (Fig. 6).
This sugar evidently acts as a bridge to enable plasma components to bind to
zymosan. It is unknown if this sugar is naturally found in B, glabrata plasma or if it
is involved in this host/parasite interaction, but more investigation seems warranted on
the effects of sugars on plasma. In addition, the effect of specific B, glabrata
polypeptides on hemocyte phagocytosis needs to be evaluated.
In the fourth series of experiments an immunoprecipitaion assay was performed.
Purified IgG that was generated to M-line plasma (anti-M) was incubated with plasma
from M-line, 13-16-Rl and 10-R2 B. glabrata. Protein A was then used to pellet the
antibody/plasma complexes and the supernatant that possibly contained unique
antigens was analyzed by SDS-PAGE. Any plasma protein(s) removed from the
supernatant of schistosome-susceptible (M-line), but left in the supernatant of
schistosome-resistant plasma (13-16-Rl or 10-R2), would identify the protein as
antigenically unique. Upon first analysis, most B. glabrata proteins remained in the
supernatant therefore more antibodies were added to the unsolubilized supernatant
(data not shown). After the second immunoprecipiation it is evident that all plasma
proteins were still present in the M-line B. glabrata supernatant sample except a 41
kDa polypeptide (Fig. 5). Hence, this 41 kDa polypeptide from schistosome-resistant
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snails appears to be antigenically unique and not removed by anti-M. To clearly
illustrate that the 41 kDa polypeptide was absent, 1.5 times as much protein from the
M-line supernatant, as compared to the other supernatants, was examined on SDSPAGE. Anti-M may not of had paratopes and/or it may not have had a strong enough
avidity for this 41 kDa polypeptide from resistant snails. Further, excessive quantities
of the 41 kDa polypeptide normally found in resistant snail plasma does not appear to
be responsible for this polypeptide not being immunoprecipitated. This is shown by
the Anding that M-line and 10-R2 plasma not immunoprecipitated show that 10-R2
and M-line plasma have relatively equal quantities of the 41 kDa polypeptide (Fig. 5).
In other words, there was not such an excess of the 41 kDa polypeptide in 10-R2
plasma that anti-M did not contain enough antibodies to remove it.
In this immunoprécipitation experiment results indicated that most plasma
proteins were not removed by anti-M (Fig. 5). Why plasma proteins were not
removed from M-line B. glabratay the snail plasma against which the antibodies were
generated, is unclear. Presumably, even though anti-M was added in excess there
evidently was not enough antibody to bind to the quantitatively dominant plasma
component. Granath et al. (1987) showed that the majority of B glabrata plasma
proteins were hemoglobin and hemoglobin subunits. Support for a lack of
hemoglobin-speciAc antibodies comes from the fact that antibodies are generated to
the most antigenic components, and not components that are in the greatest quantity.
Thus, anti-M had a mixture of antibodies that recognized the most antigenic
component(s) which may not have been the component(s) that was present in the
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largest quantity in B. glabrata plasma. Therefore, the ratio of anti-M to plasma used
probably did not contain enough antibodies specific for hemoglobin.

Alternatively,

the proteins may not have been removed because the proteins were aggregated
together and did not come in contact with the antibodies. Support for snail plasma
proteins sticking together comes from Granath et aL (1987). When they subjected
plasma to HPLC nearly all the fractions which were analyzed by SDS-PAGE, gave
polypeptide profiles similar to whole plasma. Consequently, even if proteins were not
sticking together, any polypeptides remaining in the supernatant may have given a
polypeptide profile similar to the supernatant samples (Fig. 5). Additional evidence
indicating that a polypeptide can break down to a smaller molecular weight
polypeptide is that an isolated 55 kDa polypeptide(s) from the three strains of B,
glabrata broke down to many smaller molecular weight polypeptides, but it is evident
that the 41 kDa polypeptide was not one of the breakdown products (Fig. 2).
Likewise, Spray (1989) showed that most plasma polypeptides from B. glabrata
broke-down to many smaller molecular weight polypeptides when separated on SDSPAGE a second time but, once again the 41 kDa polypeptide was not one of the
breakdown products. In addition, it was shown by Granath et al. (1987) that a band
of approximately 41 kDa was present in a hemoglobin-depleted plasma fraction from
M-line B. glabrata. From the above it appears the 41 kDa polypeptide from 13-16Rl or 10-R2 B. glabrata is unique to schistosome-resistant snails and does not appear
to be a breakdown product of any polypeptides present in B. glabrata plasma.
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A polypeptide of approximately 41 kDa was shown to be synthesized and
secreted from M-line and 10-R2 hemocytes cultured in vitro (Lodes and Yoshino,
1993). However, although not noted by these authors, this 41 kDa polypeptide
appeared to have been secreted in greater quantities by hemocytes if the hemocytes
were allowed to adhere to sporocysts. Quantitative responses have been implicated as
meaningful responses determining host/parasite compatibility (Lodes and Yoshino,
1993). In addition, proteins not associated with hemoglobin, such as the 41 kDa,
may be important in determining the ability of a snail to clear a schistosome infection
(Bayne, 1981; Granath et aZ., 1987). Furthermore, since hemocytes from
schistosome-resistant snails can be cytotoxic to sporocysts in vitro without the aid of
plasma factors (Bayne et aL, 1980a), this antigenically unique 41 kDa polypeptide
originating from hemocytes may facilitate schistosome destruction.
The fifth set of experiments in this thesis involved two-dimensional
electrophoresis of M-line, 13-16-Rl and 10-R2 B. glabrata plasma which was then
probed with antibodies to M-line, 13-16-Rl and 10-R2 B, glabrata plasma to
determine whether the 55 kDa or any other polypeptides were unique to schistosomeresistant snails. All combinations of two-dimensional separated plasma probed with
the different antibodies revealed two pairs of basic proteins in the 55 kDa molecular
weight range. Spray and Granath (1990) believed that the upper one-half of the 55
kDa range in 10-R2 plasma, as shown by SDS-PAGE, may have been the protein that
adhered to 5. mansoni sporocysts in vitro. It is noteworthy that by SDS-PAGE the
isoelectric point is not determined. In this study the upper 55 kDa band is present in
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M-line plasma as well as in 10-R2 and 13-16-Rl plasma. A protein of 55 kDa in the
middle of the pi range and an acidic protein of approximately 55 kDa was present in
addition to the doublet at the basic end (Fig. 6B, C, D; Fig. 7A, B, C; Fig. 8A, B,
C). Proteins of approximately 55 kDa formed a string of polypeptides from basic to
acidic (Fig. 7D). Antibodies to M-line, 10-R2 and 13-16-Rl plasma reacted similarly
to all 55 kDa polypeptides from all strains. Since at least one of the 55 kDa
polypeptides from schistosome-resistant snails has the unique property of binding to
primary sporocysts it must be different from the 55 kDa polypeptide of schistosomesusceptible snails. However, it is evident from this experiment that polyclonal
antibodies cannot detect this uniqueness. The antibodies probably recognized the
common carbohydrate epitope previously discussed. It can be concluded that all of
the 55 kDa polypeptides possess the common epitope.
The similarities in recognition of the 55 kDa does not negate its importance. As
discussed earlier in this thesis the 55 kDa subunit that is unique to schistosomeresistant snails may not be present until it is cleaved by a sporocyst proteinase(s).
Thus, the unique 55 kDa polypeptide may not be present since the plasma was not
exposed to ES products. If the 55 kDa subunit is a unique cleavage product of
hemoglobin it would be difficult to detect by probing with polyclonal antibodies.
Hemoglobin is a large antigenic molecule with similar multiple subunits between snail
strains. Thus a polyclonal mixture raised to the 55 kDa polypeptide also would have
many antibodies for the hemoglobin molecules. This would mask possible uniqueness
of the hemoglobin molecule.
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When M-line B. glabrata plasma was isoelectric focused, separated on SDSPAGE, blotted onto an nylon membrane and probed with homologous and
heterologous antibodies to snail plasma, polypeptides of 30 and 25 kDa from the
acidic region and polypeptides of approximately 40 kDa, ranging from basic to acidic,
often did not react with the antibodies. Counterstaining which has a sensitivity of 80
ng on nylon membranes, did not detect the polypeptides. However, repetitions of this
experiment indicated that these polypeptides were present and recognized by the
antibodies. These evasive polypeptides, when present on immunoblots of M-line
plasma appeared similar to those present on immunoblots of 10-R2 and 13-16-Rl B.
glabrata (data not shown). The factors which determine the absence or presence of
these polypeptides obviously were not elucidated. Since pooled samples were used
the factor determining the absence or presence of these polypeptides must have been
constant enough to affect all of the samples uniformly.
Plasma polypeptides of approximately 40 kDa, with a pi of basic to acidic, from
13-16-Rl plasma also were occasionally absent (Fig. 7B, C). The presence of these
40 kDa polypeptides seems to correlate with a decreased quantity of hemoglobin.
Conditions for why the hemoglobin appeared to disassociate to these 40 kDa
polypeptides is unknown. Oddly, when the 40 kDa polypeptides appeared in
immunoblots of 13-16-Rl plasma, polypeptides from the basic end were missing. It
is possible that the factor(s) which determines whether a protein is basic is the same
factor which allows the 40 kDa polypeptide to be detected in this two-dimensional
system.
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The absence of specific polypeptides by two-dimensional electrophoresis analysis
could be due to in vivo post-translational modifications (e.g. méthylation,
phosphorylation, acétylation, sulfation). If a B, glabrata plasma polypeptide was
modified in such a way that it was more basic than a pH of 7 it would not have
entered in the first dimension. Alternatively, if a polypeptide was modified in such a
way that it was more acidic than a pH of 5 it would have run all the way through the
first dimension. It is apparent that some polypeptides were modified in such a way
that they only entered the basic portion of the gel and were unable to isoelectric focus
(Fig. 6; Fig. 7D; Fig. 8). When subjected to the second dimension (SDS-PAGE)
these proteins at the basic tip of the gel appeared to have been associated with
hemoglobin. On occasion, polypeptides were absent from the acidic ends (Fig. 6;
Fig. 7C, D; Fig. 8C). These missing proteins either had a different pi which
prevented their presence in the first dimension or they had a different molecular
weight so that they would migrate to a different location.
It is known that méthylation and phosphorylation are modifications which are
reversible whereas acétylation is not (Alberts, et al., 1983). The modifications may
have been the former two, for which the variables determining reversibility were not
accounted. Changes in pi or molecular weight of a polypeptide could be the result of
carbohydrates that were associated with the polypeptide. Glycoproteins often display
heterogeneity (Spiro, 1973) and will not be resolved as a single charged species when
isoelectric focused (Dunbar, 1987). Many B. glabrata plasma proteins possess
carbohydrates (Vietri and Granath, 1992). In fact, most plasma proteins are believed
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to possess at least one common carbohydrate molecule. Support for this is that
monoclonal and anti-plasma antibodies recognized most B. glabrata plasma proteins
only when the carbohydrate was present on the proteins (Dissous et al., 1986).
Further, glycosylation can effect the binding of SDS to a protein (Dunbar, 1987). If
a protein is differentially glycosylated the quantities of SDS that can bind varies.
Although most SDS is removed in the first dimension to allow a protein to reach its
pi, trace amounts may remain. The amount and degree of remaining SDS could
affect the rate at which the protein reaches its pi (Dunbar, 1987). Length of time
protein samples were run was not found to be a significant factor affecting the
presence or absence of a protein. Since SDS was present in the solubilization buffer,
any modification that affected the hydrogen-bonding capabilities of polypeptides would
not be responsible for the presence or absence of a polypeptide.
The nutritional status of the snail may determine the presence of a polypeptide by
two-dimensional electrophoresis. Snails starved up to 24 hrs consistently had the 25
and 30 kDa acidic polypeptides, but plasma obtained from fed snails also often had
the same polypeptide profile. Thus it appears that these 25 and 30 kDa polypeptides
are not polypqitides involved with the nutritional status of a snail.
Conclusions.
This thesis took five approaches to characterize plasma factors from B. glabrata
that may play a role in resistance to the human blood fluke S. mansoni. A 55 kDa
plasma polypeptide(s) from schistosome-resistant (13-16-Rl) B. glabrata was found to
bind to living sporocysts but, when chemically-fixed, much less of this polypeptide
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bound (Fig. 1). This polypeptide is not thought to be responsible for the agglutination
of Axed sporocysts as proposed by Spray and Granath (1990). Further, it was
speculated that a proteinase(s) produced by living sporocysts may cleave the 55 kda
from the 210 kDa polypeptide. This hypothesis could be tested by incubating the 210
kDa plasma polypeptide from B. glabrata with sporocyst proteinase(s) to determine if
the 55 kDa polypeptide is a product. If it is a product it could be used to determine if
the 55 kDa polypeptide acts as an opsonin or receptor on sporocysts for hemocytes as
proposed by Spray and Granath (1990). The second series of experiments revealed
that antibodies to the purified 55 kDa polypeptide(s) from M-line, 13-16-Rl and 10R2 B. glabrata were highly cross-reactive with the majority of B. glabrata plasma
proteins. Cross-reactivity was removed by incubating the anti-55 kDa sera with B.
glabrata plasma that did not contain the 55 kDa protein(s). While removing cross
reactivity certain proteins were found to possess more of a common epitope than other
proteins (Fig. 3). The anti-55 antibodies were probably speciAc for common
carbohydrate molecules found in all B. glabrata plasma proteins. Determining the
role of glycosylated plasma polypeptides in invertebrate immunity will undoubtedly
aid in a better understanding of schistosome-snail interactions. When cross-reactivity
was removed from anti-M-55 and anti-Rl-55, antibodies reacted stronger to the 55
kDa polypeptide from M-line and 10-R2 than to the 55 kDa polypeptide from 13-16Rl B. glabrata (Fig. 4). Since the 55 kDa protein from 10-R2 and 13-16-Rl have
the ability to bind to sporocysts it is speculated that the portion of this protein
recognized by the antibodies is not involved in binding to sporocysts. In a third
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series of experiments B. glabrata plasma polypeptides were found to bind to zymosan
particles and the binding of specific polypeptides were inhibited if the particles were
preincubated with specific carbohydrates. Interestingly, the sugar N-acetylneuraminic acid resulted in most B. glabrata plasma components adhering to
zymosan. This method of allowing or preventing carbohydrate specific polypeptides
from binding to zymosan could be utilized to assess the affect of B. glabrata plasma
proteins on zymosan-phagocytosis by snail hemocytes. An immunoprécipitation
experiment to remove the common antigens between schistosome-susceptible and
resistant snails revealed that a 41 kDa polypeptide was removed from the plasma of
susceptible snails, but not from the plasma of resistant snails. Therefore, this
polypeptide is antigenically unique to resistant snails. Future techniques to
characterize this 41 kDa polypeptide from susceptible and resistant snails could
include: isolation, purification, peptide mapping, phagocytosis assays, cytokine
assays, sequencing, etc. Lastly, two-dimensional electrophoresis revealed that 3
groups of proteins exist in the 55 kDa molecular weight range in B. glabrata.
Repeating the plasma/sporocyst incubation experiments would reveal exactly which
one of these polypeptides bind to sporocysts. In addition, determining the factors
responsible for the presence or absence of polypeptides in the 25 and 30 kDa range
may reveal information about the function of these polypeptides. Performing
experiments of the type listed above will contribute further to a better understanding
of B. glabrata-schisiosomQ immunobiology.
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